Document Classification

Section Type: RESULTS

Text: There were no significant differences between the colchicine and placebo groups for the secondary end points of postoperative AF (colchicine, 61 patients [33. 9 %] ; placebo, 75 patients [41. 7 %] ; absolute difference, 7. 8 % ; 95 % CI, -2. 2 % to 17. 6 %) or postoperative pericardial/pleural effusion (colchicine, 103 patients [57. 2 %] ; placebo, 106 patients [58. 9 %] ; absolute difference, 1. 7 % ; 95 % CI, -8. 5 % to 11. 7 %), although there was a reduction in postoperative AF in the prespecified on-treatment analysis (placebo, 61/148 patients [41. 2 %] ; colchicine, 38/141 patients [27. 0 %] ; absolute difference, 14. 2 % ; 95 % CI, 3. 3 % -24. 7 %).